Early Warning Factors of Death in COVID-19 Patients

Min Shang1, Jie Wei2,3, Han-Dong Zou2,3

  • 1Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, China.

Current Medical Science
|February 14, 2021
PubMed

Insights

Early detection of COVID-19 mortality risk is crucial. Higher IL-6, lactate, older age, and lower lymphocyte counts at admission are key indicators for predicting in-hospital death in COVID-19 patients.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Biomarkers

Background:

  • The global spread and evolution of COVID-19 have led to a rapid increase in mortality.
  • Early identification of factors predicting mortality in COVID-19 patients remains a critical challenge for clinicians.
  • Understanding these factors is essential for timely intervention and improved patient outcomes.

Purpose of the Study:

  • To identify early warning factors associated with in-hospital mortality in COVID-19 patients.
  • To evaluate the predictive performance of identified factors using statistical models and ROC curve analysis.
  • To aid clinicians in identifying high-risk patients for prompt management.

Main Methods:

  • Retrospective, single-center cohort study of adult inpatients with laboratory-confirmed COVID-19.
  • Data extraction included demographic, clinical, and laboratory parameters at admission.
  • Univariable analysis, Cox proportional hazards model, and ROC curve analysis were employed to identify risk factors.

Main Results:

  • Hypertension and coronary heart disease were more prevalent in non-survivors.
  • Symptoms like dyspnea, chest distress, and fatigue were significantly higher in non-survivors.
  • Higher IL-6, lactate, older age, and lower lymphocyte counts at admission were associated with increased odds of in-hospital death.

Conclusions:

  • Elevated IL-6, lactate, advanced age, and lymphopenia at admission are significant predictors of poor prognosis in COVID-19 patients.
  • IL-6 and lymphocyte counts demonstrated high predictive accuracy for mortality.
  • These findings can assist clinicians in early risk stratification and management of COVID-19 patients.

Related Concept Videos

Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
357
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
149
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
251
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
517
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
149
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
585